The provision calls for regulators to help makers free safe drugs from prescription requirements.

"This is more than just policy talk -- it's the kind of change that could disrupt the entire health care ecosystem," said Eric Crites, senior vice president of enterprise partnerships at Q-Centrix.

“As the legal and regulatory environment changes and employee expectations shift, employers face pressure to meet compliance requirements while offering competitive benefits,” according to the latest Disability and Leave Benchmarking Report from the Marsh McLennan Agency.